Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immucell (ICCC) Return on Assets (2016 - 2025)

Historic Return on Assets for Immucell (ICCC) over the last 15 years, with Q3 2025 value amounting to 0.05%.

  • Immucell's Return on Assets rose 1400.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 1400.0%. This contributed to the annual value of 0.05% for FY2024, which is 800.0% up from last year.
  • Immucell's Return on Assets amounted to 0.05% in Q3 2025, which was up 1400.0% from 0.04% recorded in Q2 2025.
  • Immucell's Return on Assets' 5-year high stood at 0.05% during Q3 2025, with a 5-year trough of 0.14% in Q3 2023.
  • Over the past 5 years, Immucell's median Return on Assets value was 0.03% (recorded in 2021), while the average stood at 0.05%.
  • In the last 5 years, Immucell's Return on Assets tumbled by -1400bps in 2023 and then surged by 1400bps in 2025.
  • Over the past 5 years, Immucell's Return on Assets (Quarter) stood at 0.0% in 2021, then crashed by -2996bps to 0.05% in 2022, then crashed by -139bps to 0.13% in 2023, then skyrocketed by 63bps to 0.05% in 2024, then skyrocketed by 204bps to 0.05% in 2025.
  • Its last three reported values are 0.05% in Q3 2025, 0.04% for Q2 2025, and 0.01% during Q1 2025.